Integra LifeSciences sets sights on acquiring J&J's Codman Neurosurgery business: 7 insights

Spinal Tech

Plainsboro, N.J.-based Integra LifeSciences made a binding offer to acquire Johnson & Johnson's Codman Neurosurgery business, based in Raynham, Mass.

Here are seven insights:

 

1. Integra LifeSciences' offered a price of $1.05 billion in cash.

 

2. The Codman Neurosurgery portfolio includes devices for hydrocephalus, neuro-critical care and operative neurosurgery.

 

3. Integra hopes to combine Codman's neurosurgery portfolio with its tissue ablation, dural repair and cranial stabilization products to offer a comprehensive neurosurgery portfolio.

 

4. In 2016, the Codman neurosurgery products generated about $370 million in revenue.

 

5. Integra anticipates the transaction to be accretive to adjusted earnings-per-share by $0.22 at least in the first full year post-closing.

 

6. While Integra expects the Codman Neurosurgery revenue to see some disruption in the first year after acquisition, the company believes it will increase 3 percent to 6 percent in the longer term.

 

7. After the information and consultation process with the employees' representatives in other countries concludes, Integra plans to enter into a definitive purchase and sale agreement.

 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like